These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 18580244

  • 1. Demonstration of thyroidal metastasis from lung cancer by F-18 FDG PET scan.
    Jackson RT, Sinha P, Conrad GR.
    Clin Nucl Med; 2008 Jul; 33(7):505-6. PubMed ID: 18580244
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Metastasis to the thyroid from non-small cell carcinoma of the lung: findings in (18)F-FDG PET/CT study.
    Agrawal K, Weaver J, Mohan HK.
    Endocrine; 2015 Mar; 48(2):720-1. PubMed ID: 24853886
    [Abstract] [Full Text] [Related]

  • 4. Metastatic malignant melanoma to the thyroid gland detected by FDG-PET imaging.
    Basu S, Alavi A.
    Clin Nucl Med; 2007 May; 32(5):388-9. PubMed ID: 17452870
    [No Abstract] [Full Text] [Related]

  • 5. 18F-FDG PET/CT demonstrating response to targeted therapy in synchronous metastatic adenocarcinoma of the lung and poorly differentiated carcinoma of the thyroid.
    Kumar NS, Basu S.
    Natl Med J India; 2015 May; 28(3):155. PubMed ID: 26724353
    [No Abstract] [Full Text] [Related]

  • 6. Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer.
    Yi JG, Marom EM, Munden RF, Truong MT, Macapinlac HA, Gladish GW, Sabloff BS, Podoloff DA.
    Radiology; 2005 Jul; 236(1):271-5. PubMed ID: 15987980
    [Abstract] [Full Text] [Related]

  • 7. F-18 FDG PET demonstration of a thyroid metastasis in a patient with colon cancer.
    Iguchi T, Matsuoka J, Sato S, Okumura Y, Omori M, Mifune H, Akaki S, Kanazawa S.
    Clin Nucl Med; 2007 May; 32(5):361-2. PubMed ID: 17452862
    [Abstract] [Full Text] [Related]

  • 8. Detection of thyroid malignancy in a hot nodule by fluorine-18-fluorodeoxyglucose positron emission tomography.
    Low SC, Sinha AK, Sundram FX.
    Singapore Med J; 2005 Jun; 46(6):304-7. PubMed ID: 15902360
    [Abstract] [Full Text] [Related]

  • 9. The role of F-18-fluorodeoxyglucose positron emission tomography in the postoperative evaluation of differentiated thyroid cancer.
    Alzahrani AS, Abouzied ME, Salam SA, Mohamed G, Rifai A, Al Sugair A, Amin T.
    Eur J Endocrinol; 2008 May; 158(5):683-9. PubMed ID: 18426827
    [Abstract] [Full Text] [Related]

  • 10. F-18 FDG PET/CT demonstration of an adrenal metastasis in a patient with anaplastic thyroid cancer.
    Iagaru A, McDougall IR.
    Clin Nucl Med; 2007 Jan; 32(1):13-5. PubMed ID: 17179796
    [Abstract] [Full Text] [Related]

  • 11. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
    Lind P, Kohlfürst S.
    Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
    [Abstract] [Full Text] [Related]

  • 12. Elevated FDG uptake in right middle segmental bronchus impacted with foreign body.
    Xing Y, Zhao J, Chen X, Song J.
    Clin Nucl Med; 2009 Apr; 34(4):241-2. PubMed ID: 19300058
    [Abstract] [Full Text] [Related]

  • 13. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
    Chung JK, So Y, Lee JS, Choi CW, Lim SM, Lee DS, Hong SW, Youn YK, Lee MC, Cho BY.
    J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
    [Abstract] [Full Text] [Related]

  • 14. Histological aggressiveness of fluorodeoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid carcinomas.
    Are C, Hsu JF, Ghossein RA, Schoder H, Shah JP, Shaha AR.
    Ann Surg Oncol; 2007 Nov; 14(11):3210-5. PubMed ID: 17713821
    [Abstract] [Full Text] [Related]

  • 15. [Thyroid metastases of pulmonary origin diagnosed by (18)F-FDG PET-CT].
    Moragas M, Moreno C, Mourelo S, Soler M, Riera E, García JR.
    Rev Esp Med Nucl Imagen Mol; 2014 Nov; 33(4):243-4. PubMed ID: 24656755
    [No Abstract] [Full Text] [Related]

  • 16. Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP).
    Specht JM, Tam SL, Kurland BF, Gralow JR, Livingston RB, Linden HM, Ellis GK, Schubert EK, Dunnwald LK, Mankoff DA.
    Breast Cancer Res Treat; 2007 Sep; 105(1):87-94. PubMed ID: 17268819
    [Abstract] [Full Text] [Related]

  • 17. The added benefit of a dedicated neck F-18 FDG PET-CT imaging protocol in patients with suspected recurrent differentiated thyroid carcinoma.
    Davison JM, Stocker DJ, Montilla-Soler JL, Jurgens JS, Allen TW, Holley TS, Stack AL.
    Clin Nucl Med; 2008 Jul; 33(7):464-8. PubMed ID: 18580230
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.
    Lee ST, Berlangieri SU, Poon AM, Mitchell P, Pathmaraj K, Tabone K, Byrne AJ, O'Keefe GJ, Knight SR, Clarke CP, Scott AM.
    Intern Med J; 2007 Nov; 37(11):753-9. PubMed ID: 17517082
    [Abstract] [Full Text] [Related]

  • 19. Uterine leiomyosarcoma metastatic to thyroid shown by 18F-FDG PET/CT imaging.
    Gauthé M, Testart Dardel N, Nascimento C, Trassard M, Banal A, Alberini JL.
    Rev Esp Med Nucl Imagen Mol; 2017 Nov; 36(2):113-115. PubMed ID: 27777040
    [Abstract] [Full Text] [Related]

  • 20. [Clinical application of (18)F-FDG PET/CT to staging and treatment effectiveness monitoring of nasopharyngeal carcinoma].
    Wang GH, Lau EW, Shakher R, Binns DS, Hogg A, Drummond E, Hicks RJ.
    Ai Zheng; 2007 Jun; 26(6):638-42. PubMed ID: 17562272
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.